SCHEMBL29700435

SCHEMBL29700435

COC(=O)c1ccnc(CS(C)(=O)=O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.51
KDM4C Q9H3R0 2/20 0.51
KDM6B O15054 1/20 0.51
KDM5C P41229 1/20 0.51
KDM2A Q9Y2K7 1/20 0.51
KDM3A Q9Y4C1 1/20 0.51
ALOX15 P16050 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
JMJD6 Q6NYC1 1/20 0.46
HPGD P15428 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
KDM5B Q9UGL1 3/20 0.43
KDM5A P29375 2/20 0.43
POLB P06746 1/20 0.43
ACLY P53396 1/20 0.43
HSD17B10 Q99714 2/20 0.42
HTT P42858 1/20 0.42
DYRK1A Q13627 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL346941 1.00 KDM4E (0.51) KDM4EKDM4CKDM6BKDM5CKDM2A
SCHEMBL26567184 0.87 KDM4C (0.37) KDM4EKDM4CKDM6BKDM5CKDM2A
SCHEMBL26566973 0.83 GABRP (0.51) KDM4EKDM4CKDM6BKDM5CKDM2A
SCHEMBL348768 0.82 KDM4E (0.49) KDM4EKDM4CKDM6BKDM5CKDM2A
SCHEMBL14993600 0.81 MBOAT4 (0.45) KDM4EKDM4CKDM5CSMN1; SMN2KDM5B
SCHEMBL10263738 0.81 KDM4E (0.57) KDM4EKDM4CKDM6BKDM5CKDM2A
SCHEMBL30740808 0.81 KDM4C (0.57) KDM4EKDM4CKDM6BKDM5CKDM2A
SCHEMBL348975 0.81 KDM4C (0.57) KDM4EKDM4CKDM6BKDM5CKDM2A
SCHEMBL31320065 0.81 KDM4E (0.57) KDM4EKDM4CKDM6BKDM5CKDM2A
Lithium Ion SCHEMBL29700415 0.80 KDM5C (0.51) KDM4EKDM4CKDM6BKDM5CKDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251615-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 EP disclosed
WO-2022112188-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 WO disclosed